Suppr超能文献

1995 年至 2014 年爱沙尼亚宫颈癌发病率和生存率的变化趋势。

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.

机构信息

Oncology Center, East Tallinn Central Hospital, Ravi 18, 10138, Tallinn, Estonia.

Department of Epidemiology and Biostatistics, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia.

出版信息

BMC Cancer. 2018 Nov 7;18(1):1075. doi: 10.1186/s12885-018-5006-1.

Abstract

BACKGROUND

Cervical cancer (CC) incidence in Estonia is the third highest in Europe, even though an organised nation-wide screening program has been in place since 2006. The aim of the study was to analyse the incidence and survival of CC in Estonia, focusing on age, morphology and stage at diagnosis.

METHODS

Data from Estonian Cancer Registry were used to analyse age-standardized (world) and age-specific incidence for 1968-2014 rates. Joinpoint regression was used to estimate the annual percentage change (APC) for incidence trends. Age-period-cohort model was used to summarise time trends in terms of cohort and period effects. Relative survival ratios (RSR) were calculated for cases diagnosed in 1995-2014. Union for International Cancer Control version 7 of the TNM classification for malignant tumours was used to categorise stage.

RESULTS

The age-standardized incidence of CC increased since 1980s at a rate of 0.8% per year. A significant increase was seen for all age groups except for 70+. The incidence of squamous cell carcinoma mimicked the overall trend, while adenocarcinoma showed increase since mid-1990s (APC 6.7). Age-period-cohort modelling showed strong cohort effects with the lowest risk for birth-cohorts born around 1940 and significantly increasing risks for successive cohorts born thereafter. No period effects were seen. The proportion of stage IV cases increased from 13% in 2005-2009 to 18% in 2010-2014. A significant increase was seen in the overall 5-year RSR from 1995 to 1999 to 2010-2014 (58% vs 66%). In 2010-2014, the 5-year RSRs ranged from 89% in women aged 15-39 to 41% in age group 70+. For stages I to IV, the respective RSRs were 98, 74, 57 and 22%.

CONCLUSIONS

The inadequate uptake and insufficient quality of the Pap-smear based screening program has not brought along a decline in the incidence of CC in Estonia. Stage distribution has shifted towards later stages. New approaches are needed to prevent CC in Estonia.

摘要

背景

尽管自 2006 年以来,爱沙尼亚已开展全国性的宫颈癌组织筛查,但该国的宫颈癌发病率仍为欧洲第三高。本研究旨在分析爱沙尼亚宫颈癌的发病和生存情况,重点关注发病时的年龄、形态和分期。

方法

本研究使用爱沙尼亚癌症登记处的数据,分析了 1968 年至 2014 年期间的年龄标准化(世界)和年龄特异性发病率。采用 Joinpoint 回归估计发病率趋势的年百分比变化(APC)。采用年龄-时期-队列模型,以队列和时期效应的形式总结时间趋势。计算了 1995-2014 年诊断病例的相对生存率(RSR)。采用国际癌症控制联盟第 7 版恶性肿瘤 TNM 分类来划分分期。

结果

自 20 世纪 80 年代以来,爱沙尼亚宫颈癌的发病率呈上升趋势,每年上升 0.8%。除 70 岁以上人群外,所有年龄组的发病率均有所上升。鳞癌的发病趋势与总体趋势相似,而腺癌的发病率自 20 世纪 90 年代中期以来有所上升(APC 为 6.7)。年龄-时期-队列模型显示出强烈的队列效应,出生于 20 世纪 40 年代左右的队列风险最低,而此后出生的队列风险显著增加。未观察到时期效应。IV 期病例的比例从 2005-2009 年的 13%上升至 2010-2014 年的 18%。1995-1999 年至 2010-2014 年,总体 5 年 RSR 显著升高(58%比 66%)。2010-2014 年,15-39 岁女性的 5 年 RSR 为 89%,70 岁以上女性的 RSR 为 41%。I-IV 期的相应 RSR 分别为 98%、74%、57%和 22%。

结论

由于巴氏涂片筛查的参与度不足且质量不高,爱沙尼亚的宫颈癌发病率并未下降。分期分布已向晚期转移。需要采取新的方法来预防爱沙尼亚的宫颈癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf3/6222998/65d7ceb904ba/12885_2018_5006_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验